Drug Shortage Report for RABEPRAZOLE
Report ID | 120575 |
Drug Identification Number | 02385457 |
Brand name | RABEPRAZOLE |
Common or Proper name | RABEPRAZOLE |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | RABEPRAZOLE SODIUM |
Strength(s) | 20MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-06-15 |
Estimated end date | 2020-08-31 |
Actual end date | 2020-08-24 |
Shortage status | Resolved |
Updated date | 2020-08-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-08-28 | French | Compare |
v3 | 2020-08-28 | English | Compare |
v2 | 2020-07-17 | French | Compare |
v1 | 2020-07-17 | English | Compare |
Showing 1 to 4 of 4